A. Montag and Associates »

Ernexa Therapeutics shares owned by A. Montag and Associates

Quarter-by-quarter ownership of Ernexa Therapeutics (ERNA) shares owned by A. Montag and Associates from 13F filings

Historical chart of A. Montag and Associates investment in Ernexa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ernexa Therapeutics held by A. Montag and Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ernexa Therapeutics by A. Montag and Associates

Quarter filed Position value Share count Share price at filing
2025-09-30 $9 8 1.13
2025-06-30 $15 8 1.88

More positions owned by A. Montag and Associates

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Ishares Tr Rus 1000 Etf (IWB)
Nvidia Corporation Call Call Option (Principal) (NVDA)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Home Depot (HD)
JPMorgan Chase & Co. (JPM)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Specialized Funds Div App Etf (VIG)
Broadcom Call Call Option (Principal) (AVGO)

View all positions for A. Montag and Associates

Top funds holding Ernexa Therapeutics

CI Private Wealth
Susquehanna International
Geode Capital Management
Vanguard Group
Sippican Capital Adivsors
Tower Research Capital
BlackRock
Morgan Stanley
Assetmark
EverSource Wealth Advisors
Bnp Paribas Arbitrage, Snc
A. Montag and Associates
Activest Wealth Management

View all funds holding Ernexa Therapeutics